We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Self-Expanding Heart Valve Treats Severe Aortic Stenosis

By HospiMedica International staff writers
Posted on 21 Mar 2018
Print article
Image: The Centera THV system (Photo courtesy of Edwards Lifesciences).
Image: The Centera THV system (Photo courtesy of Edwards Lifesciences).
A novel transcatheter heart valve (THV) valve aids treats patients with severe aortic stenosis requiring aortic valve replacement (AVR).

The Edwards Lifesciences (Irvine, CA, USA) Centera THV system is an ultra-low-profile self-expandable valve that consists of three treated bovine pericardial tissue leaflets attached to a nitinol frame and polyethylene terephthalate (PET) fabric. The stent frame is short, and therefore does not have a flared distal section that extends into the ascending aorta, facilitating centering and seating of the valve within the annulus. The shorter frame may also help to improve paravalvular sealing due to minimal protrusion of the valve frame into the left ventricle. Centera is available in 23 mm and 26 mm sizes.

The THV is provided with the valve pre-attached to the delivery system, facilitating rapid placement using a low-profile, 14F motorized delivery system that allows single-operator repositioning and retrieval. A dynamic expansion mechanism (DEM) allows transient sheath compression during valve delivery; immediately after it passes through, the DEM allows the sheath to return to its original low-profile diameter. Buttons control valve loading and deployment, while a handle release button and valve release mechanism permit the final release of the device.

“The Edwards Centera valve demonstrates extremely favorable early clinical safety and performance outcomes in the high surgical risk TAVR population,” said Didier Tchétché, MD, of Clinique Pasteur (Toulouse, France). “In addition to excellent patient outcomes, the valve also offers several unique features and an innovative tissue design, all of which simplify the procedure for clinicians.”

THV, sometimes called transcatheter aortic valve implantation (TAVI), may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It can also be indicated in those who cannot undergo open-heart surgery.

Related Links:
Edwards Lifesciences
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgical Table
STERIS 5085 SRT

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more